Postmenopausal estrogen and the risk of breast cancer. The need for randomized trials.
Rossouw
J E
JE
Harlan
W R
WR
D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D012307:Risk Factors
D004966:Estrogens, Conjugated (USP)